Codiak BioSciences, Inc. announced it has appointed Lini Pandite, MBChB, MBA to its board of directors. As a board-certified oncologist and current Chief Medical Officer at Shattuck Labs, Dr. Pandite brings extensive expertise in oncology drug development and clinical application, diversifying the breadth of expertise represented on the board. Prior to joining Shattuck Labs, Dr. Pandite served as Senior Vice President, Head of Clinical Development at Adaptimmune. She also spent several years with GlaxoSmithKline culminating in her tenure as Vice President, Head Unit Physician for Oncology R&D. Her broad oncology drug development expertise spans early-to-late phase development from pre-IND through marketing authorization and commercialization.